Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

Texas: Volunteers Needed for HIV Vaccine Trial

January 19, 2012

The University of Texas Southwestern continues to recruit local volunteers for Phase II of an HIV vaccine trial underway at nearly two dozen sites across the nation. Researchers are seeking healthy men ages 18 to 50 who are circumcised, HIV-negative, and have sex with other men. Transgender women who have sex with men are also needed. Participation requires a 12- to 18-month commitment, said Ernesto Gallegos, a member of the Clinical Research Unit Community Advisory Board. The vaccine cannot cause HIV, and Phase I testing established it can be given safely to humans. Half the participants receive the vaccine, while the others receive a placebo. Volunteers are asked to keep a written record of any reaction to the four shots, and they are required to return to UT Southwestern once every three months for an interview, risk-reduction counseling, and an HIV test. For more information, telephone 214-590-0610 or visit www.HopeTakesAction.org.

Back to other news for January 2012

Adapted from:
Dallas Voice
01.12.2012; David Taffet


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
Texas

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement